Big Pharma M&A will likely take a hit if the U.S. government lives up to its threats of imposing tariffs on the industry, ...

Roche Holding, the Swiss pharmaceutical giant, said on Thursday that its group sales rose by 7% in the first quarter to 14.4 ...

To strengthen its U.S. presence, Roche is building up inventory, ramping up production at three of its U.S. plants and relocating one manufacturing site to the U.S. through a technology transfer, its ...

During the three-day visit, the Swiss delegation will highlight Switzerland’s substantial investments in the United States, ...

Investing.com - European equity indices mainly slipped lower Thursday as the relief rally stalled, with investors digesting a ...

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...

Investing.com -- Roche on Thursday reported a 6% increase in group sales for the first quarter of 2025, driven by strong ...

COPENHAGEN (Reuters) -Danish biotechnology company Zealand Pharma said on Thursday it had enrolled the first patient in a mid-stage trial with its weight-loss drug candidate petrelintide in people ...

FRANKFURT: Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer ...

Base metals were broadly higher. Risk appetite is improving and buyers are returning, reflecting some short-term optimism surrounding potentially de-escalating trade tensions, said Sucden Financial.

Swiss drugmaker Roche said on Thursday its first-quarter sales rose 7% to 15.44 billion Swiss francs ($18.64 billion) and it ...